The biological processes underlying stroke are complex, and patients have a narrow repertoire of therapeutic opportunities. After the National Institutes of Health (NIH) convened the Stroke Progress Review Group in 2001, stroke research shifted from having a purely neurocentric focus to adopting a more integrated view wherein dynamic interactions between all cell types contribute to function and dysfunction in the brain. This so-called ''neurovascular unit'' provides a conceptual framework that emphasizes cell-cell interactions between neuronal, glial, and vascular elements. Under normal conditions, signaling within the neurovascular unit helps maintain homeostasis. After stroke, cell-cell signaling is disturbed, leading to pathophysiology. More recently, emerging data now suggest that these cell-cell signaling mechanisms may also mediate parallel processes of neurovascular remodeling during stroke recovery. Because plasticity is a signature feature of the young and developing brain, these concepts may have special relevance to how the pediatric brain responds after stroke.
Stroke is now the second leading cause of death and is one of the most devastating diseases worldwide. Although the disease burden is enormous, stroke patients still have few therapeutic options. For ischemic stroke, acute treatments are limited to reperfusion with tissue plasminogen activator or mechanical catheter-devices. For acute intracerebral hemorrhage, current surgical and medical therapies are extremely limited in efficacy.
Early drug discovery investigations in stroke were mostly focused on prevention of neuronal death. However, the complex pathophysiology of stroke ultimately involves interactions between multiple cell types, so a focus on saving neurons alone might not be sufficient. In 2001, the National Institute of Neurological Disorders and Stroke convened the Stroke Progress Review Group to explore new directions for stroke research, and at this workshop, the concept of ''neurovascular unit'' was introduced. 1 Fundamentally, this concept emphasized that brain function and dysfunction arise from integrated interactions between a network of neurons, glia, and cerebral endothelium. Coordinated responses at the neurovascular interface will mediate not only acute but also chronic events in ischemic and hemorrhagic brain tissue. 2, 3 During the early acute phase after stroke onset, loss of cell-cell signaling in the neurovascular unit leads to pathophysiology. During the delayed phase, cell-cell signaling between neurons, glia, and vessels may provide the critical neurovascular substrates for functional plasticity and remodeling.
In this mini review, we will briefly survey this basic idea (ie, cell-cell crosstalk in the neurovascular unit mediates both acute injury as well as delayed recovery). Although data in this field are still dominated by findings in adult brains, these concepts will surely be even more important in the pediatric brain because plasticity is a signature feature of the young and developing central nervous system.
Neurovascular Damage in the Acute Phase
Stroke is a heterogeneous spectrum of conditions caused by the interruption of blood vessels supplying the brain. 4, 5 In ischemic strokes, severe blood flow deficits in the core rapidly decrease adenosine triphosphate levels and energy stores. Because cell death processes in this area occur within minutes, it may be difficult to protect the cells using drug treatments. In contrast, cells in the surrounding region (so-called penumbra) suffer milder insults because of residual perfusion from collateral blood vessels. In the penumbra, cells die more slowly by active cell death mechanisms, and therefore therapeutic approaches are theoretically possible (Figure 1 ). In hemorrhagic strokes, areas surrounding the central hematoma may also suffer from expanding edema, progressive inflammation, and cell death, although the molecular mechanisms are less well defined compared with ischemic strokes.
The fundamental mechanisms of brain cell death in the acute stroke phase are complex. However, data accumulated over the past 2 decades have implicated excitotoxicity, oxidative stress, and, in some circumstances, apoptotic-like pathways. 4, 6 When the brain fails to generate sufficient adenosine triphosphate by reduction of blood flow supply, energy failure occurs and ionic gradients are lost. Glutamate reuptake processes are impaired, and accumulated glutamate promotes excessive calcium entry and release. Calcium-dependent synthases and proteases contribute to neuronal death by degrading key cytoskeletal and enzymatic proteins. Abnormality of calcium homeostasis also generates nitric oxide and peroxynitrite, which directly strike neighboring cells. Moreover, mitochondrial functions such as oxidative phosphorylation fail, and reactive oxygen radicals are released that further compromise cells by attacking proteins, lipids, and nucleic acids. In parallel with these ionic and free radical pathways, deleterious molecules such as caspases may also promote cell death by suicidal endogenous mechanisms. However, most of the cell death pathways outlined here are well documented for neurons. Whether similar mechanisms should be targeted for glial and vascular compartments remains to be carefully assessed.
Besides basic cell death mechanisms, one of the most important facets of early neurovascular damage is manifested as perturbations in blood-brain barrier function. Blood-brain barrier homeostasis is remarkably dependent on endothelialastrocyte-matrix interactions. 7, 8 Perturbation of the neurovascular matrix (type IV collagen, heparan sulphate proteoglycan, laminin, fibronectin, etc) disrupts the cell-matrix and cell-cell signaling that maintain neurovascular functions. Many proteinases might contribute to extracellular matrix proteolysis, and the extracellular protease systems become dysregulated under diseased conditions. In particular, roles of the matrix metalloproteinase family have been focused in the neurovascular damage after stroke. 9 Matrix metalloproteinase levels are increased in both experimental models of stroke [10] [11] [12] and stroke patients. 13, 14 Those excessive matrix metalloproteinase activities might be deleterious. Matrix metalloproteinases can degrade the extracellular matrix that comprises the basal lamina, thus damaging the blood-brain barrier directly. In experimental stroke models, matrix metalloproteinase inhibition reduces infraction and edema. 15, 16 In addition to blood-brain barrier disruption, matrix metalloproteinase-induced proteolysis of the neurovascular matrix might also promote programmed cell death by the detachment of cells from the extracellular matrix (so-called ''anoikis''). 17, 18 These findings suggest that matrix metalloproteinases (and other extracelluar proteases) mediate neurovascular damage during the acute stages of stroke.
Ultimately, these neurovascular perturbations can also be interpreted as dysfunctional crosstalk between components of the neurovascular unit. Lack of proper signaling between endothelium and astrocytes may underlie blood-brain barrier leakage. Lack of proper signaling between neurons and endothelium may interfere with hemodynamic coupling required for functional brain activation. Lack of proper signaling between neurons and glia may impede normal neurotransmitter releasereuptake kinetics as well as communications along axons. Hence, preventing neuronal death alone will surely not suffice. Saving all these functional interactions across multiple cell types will be required for any truly effective therapy.
Despite convincing experimental evidence, none of the previously described cell death pathways or neurovascular mechanisms have been successfully exploited for treating acute stroke patients. Although many translational barriers are involved, 19, 20 the heterogeneity of patients and tight timelines during acute pathology make it difficult to block these early targets efficiently. Therefore, a recent emphasis in the field focuses on assessing opportunities for promoting neurovascular recovery after stroke.
Neurovascular Repair in the Chronic Phase
Most stroke patients show some degree of recovery over time. For example, functional magnetic resonance imaging (MRI) Figure 1 . In central core areas of stroke, blood flow deficits and/or hemorrhagic lesions are severe and brain cells die rapidly. In peripheral areas (the penumbra), it has been proposed that cell death, inflammation, and neurovascular perturbations proceed at a slower pace. Hence, therapeutic salvage is theoretically possible. studies demonstrate that peri-infarct areas are highly plastic. 21, 22 Representational areas shift as latent networks are unmasked and parallel circuits are recruited adjacent to damaged regions. 23 However, the underlying cellular mechanisms for these recovery processes are not yet fully understood.
The primary neurovascular responses during stroke recovery phase are thought to involve angiogenesis and neurogenesis. Molecular mechanisms of angiogenesis and neurogenesis have been evolutionarily conserved so that similar mediators and pathways are involved in both phenomena. 24 It is now accepted that cell-cell signaling between cerebral endothelium and neuronal precursor cells helps mediate and sustain pockets of ongoing angiogenesis and neurogenesis in the adult brain. 8, 22, [25] [26] [27] These endothelial-brain interactions comprise the neurovascular niche. Crosstalk between the vascular and neuronal compartments in the neurovascular niche is mediated by an exchange of soluble signals. This phenomenon is partly mediated by the ability of cerebral endothelium to secrete a rich repertoire of trophic factors. [28] [29] [30] In the normal brain, the neurovascular niche defines these complex mechanisms of cell-cell signaling between cerebral endothelium and neural precursors in the subventricular and subgranular zones of ongoing neurogenesis. In the context of poststroke recovery, these close relationships between neurogenesis and angiogenesis are maintained. Neuroblasts migrate along perivascular routes. 31 Promotion of neurogenesis enhances vascular regrowth and, conversely, angiogenic stimulation enhances neurogenesis. 32, 33 Angiogenesis in peri-infarct regions has been detected in rodent models of cerebral ischemia 34 as well as in human stroke. 35 Hence, brain recovery after stroke comprises interdependent neurovascular plasticity and remodeling processes that recruit multiple common mediators and signals. 24 Therapies that can boost these endogenous signals and substrates of neurovascular remodeling might be a new direction for stroke treatments. 36 However, it remains to be fully elucidated how these approaches can be used in the clinic. It is worth noting that most molecular targets for stroke therapy have biphasic roles in stroke pathophysiology. 2, 37 As mentioned in the previous section, during the acute phase, matrix metalloproteinases mediate neurovascular damage through the interruption of cell-cell trophic coupling. During the chronic phase, on the other hand, the same mediators may contribute to neurovascular recovery. In a mouse stroke model, endothelial and glial cells in peri-infarct areas showed a secondary elevation in matrix metalloproteinase-9, and pharmacological inhibition of matrix metalloproteinases during the delayed phase made outcomes worse. 38 Furthermore, secondary matrix metalloproteinase-9 signals colocalized with streams of migrating neuroblasts from the subventricular zone, and matrix metalloproteinase inhibition also blocked the movement of these neuroblasts, which headed toward the damaged region. 39 In addition, vascular endothelial growth factor and highmobility group protein 1 are other examples for biphasic mediators in neurovascular responses after stroke. Vascular endothelial growth factor increases blood-brain barrier permeability in the acute phase, and accelerates angiogenesis/ neurogenesis in the delayed stroke phase. 40, 41 High-mobility group protein 1 is normally present in the nucleus and is released extracellulary in response to ischemic stress. During the acute stroke phase, high-mobility group protein 1 promotes necrosis and influx of damaging inflammatory cells. In contrast, during the delayed phase, high-mobility group protein 1 mediates beneficial plasticity and recovery in the neurovascular unit. 42 Likewise, many mediators in the neurovascular unit have biphasic roles (ie, harmful effects in the acute phase and beneficial in the chronic phase). Hence, neurovascular protection may not be achieved without considering the timing when the initial deleterious responses transit into recovering mechanisms.
Cell-Cell Trophic Coupling in White Matter
For the most part, the concept of the neurovascular unit is used to guide investigation in gray matter. However, cell-cell trophic interactions are likely to be important in white matter as well. White matter is vulnerable to ischemic stress and white matter damage is a clinically important part of stroke. 4, 43 Therefore, without considering oligo-protection, we may not be able to protect the brain against stroke insult. Compared with the cellular mechanisms of neurovascular damage/repair in gray matter, white matter pathophysiology remains relatively understudied and poorly understood. However, the idea of the neurovascular unit is now applied to white matter stroke research.
The main components of white matter are the neuronal axon, oligodendrocyte (myelin), astrocyte, and endothelium. As in the neurovascular unit in gray matter, astrocytes and cerebral endothelial cells work together to maintain blood-brain barrier in white matter. 43 In addition, astrocytes are in close apposition to oligodendrocytes within white matter 44 and couple with oligodendrocytes through gap junctions to maintain their functions. 45 Furthermore, astrocyte-derived soluble factors were also reported to nourish oligodendrocyte lineage cells. 46, 47 And, of course, myelin-axon interactions are essential for white matter homeostasis. Oligodendrocytes not only myelinate axons but also maintain their functional integrity and survival through oligodendrocyte-specific proteins and/or trophic factor release. 48, 49 Similar to gray matter, during the acute phase of stroke, several deleterious factors/cascades are activated. For example, matrix metalloproteinases are upregulated, and direct attack of matrix metalloproteinases on myelin components affects oligodendrocyte survival and function. 50 Even if outright cell death does not occur, metabolic dysfunctions in oligodendrocytes might still affect the normal replenishment of myelin and synthesis of myelin-associated proteins, which eventually impair myelin-axon interactions.
In the chronic phase, some endogenous responses might work for repairing white matter damage. White matter in the adult brain primarily consists of axonal bundles ensheathed with myelin by mature oligodendrocytes and plays an important role in passing signals between different areas of gray matter. During development, oligodendrocyte precursor cells migrate from the ventricular zone to their final destination, and then differentiate to form myelin sheaths. 51, 52 Oligodendrocyte precursor cells are now well-known to be widely distributed even in the adult brain. 53 And importantly, after brain injury, they are guided to the site for contributing to myelin repair. 53 It remains to be fully elucidated how oligodendrogenesis occurs during the chronic phase, however, cell-cell trophic interactions might be involved in this phenomena. As in the so-called neurovascular niche, an oligovascular niche might play an important role in supporting trophic interactions between brain endothelium and oligodendrocyte precursor cells. 54 Hence, cell-cell trophic coupling in white matter may provide an essential mechanism for repairing damaged white matter in the chronic stroke phase.
Conclusions and Potential Implications for the Developing Brain
It is now a decade since the concept of neurovascular unit was first introduced. This concept has provided a novel framework for both basic and clinical stroke research. A purely neurocentric focus has been shifted into a more integrated view wherein dynamic interactions between all cell types contribute to function and dysfunction in the brain. As we have seen in this mini-review, multiple mediators induce neurovascular dysfunction in the acute stroke phase. In contrast, the same mediators in turn may underlie neurovascular repair processes in the chronic stroke phase. Understanding cellular mechanisms of the transition zones between injury and repair will give us new directions for stroke treatments. More recently, this concept of the neurovascular unit has grown far beyond its original roots in stroke. The idea that cell-cell signaling in all brain cells comprises the basis for both function and dysfunction is now well-accepted in many other central nervous system disorders ( Figure 2) .
Although most patients suffering from stroke and neurodegenerative diseases typically comprise an elderly population, lessons from ongoing studies suggest these concepts should also be relevant for the developing central nervous system. Crosstalk and signaling between multiple cell types is a central event for central nervous system development and maturation. Hence, the notion that a damaged brain is surprisingly plastic will surely present many parallels with the young and developing brain. Simultaneous neural and vascular remodeling has been observed in neonatal brain injury. 55, 56 And, in contrast to the older brain, poststroke profiles in the developing brain will encompass long periods of recovery, so proper remodeling of the neurovascular unit will be extremely important. However, it is also useful to remember there will be key differences in how the young and older brains respond to stroke and injury, especially in the context of inflammation. 57 This will be an area that warrants further investigations.
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